期刊文献+

淫羊藿对糖皮质激素大鼠肾脏损害的预防作用及对骨形态发生蛋白-7的影响 被引量:4

Epimedium prevented glucocorticoid- induced kidney damages by regulation of bone morphogenetic protein- 7 in rats
下载PDF
导出
摘要 目的观察醋酸泼尼松对大鼠肾脏组织形态学和功能的影响,探讨淫羊藿(EP)对糖皮质激素(GC)大鼠肾脏损害的预防作用及对骨形态发生蛋白-7(BMP-7)的影响。方法 3月龄SD大鼠24只随机分为3组:正常对照(Cont组)组、糖皮质激素组(GC组)和淫羊藿防治组(GC+EP组),均为上午选模给药,下午防治给药,灌胃给药90 d。苏木素-伊红染色法观察肾脏组织形态学,分光光度计比色法测定血清肌酐和尿素氮(BUN)含量,免疫组化法检测肾脏BMP-7的表达。结果 GC组大鼠部分肾小球明显萎缩,个别肾小管萎缩,少数肾小管有蛋白管型,BUN含量增高(P<0.01),肾脏BMP-7表达减少(P<0.01);与GC组比较,GC+EP组肾小球基本正常,肾小管未见明显萎缩,无蛋白管型的发生,BUN含量和肾脏BMP-7表达正常(P<0.001)。结论EP可通过上调肾脏BMP-7表达预防GC所致的肾脏结构和功能损害。 Objective To observe the renal histomorphologicaland functional change induced by glucocorticoid (GC) in rats, and to further investigate the protective effects of epimedium (EP) on GC - induced kidney damages by regulating bone morphogenetic protein - 7 ( BMP - 7 ). Methods Twenty - four SD rats of 3 - month were randomly divided into three groups: the normal group (Group C ) , the GC group (Group G) and the GC plus EP treatment group ( Group T) ;in which all drugs were given for 90 days. Hematoxylin - eosin (HE) staining was used for renal pathological observation, while spectrophotometer was applied for assessment of serum creatinine and blood urea nitrogen, and immuno- histochemical analysis was used to assessthe expression of kidney BMP - 7. Results Notable aeinusrenisatrophia, morderate renal tubule atrophia, and several protein cast inrenal tubules were observed with significant elevation of BUN and down - regulation of BMP -7 in Group G (P 〈0. 01 ) ; which were significantly reversed by EP treatment in Group T(P 〈 0. 001 ). Conclusion EP can prevent GC - induced kidney damages in rats by up - regulating renal BMP - 7 expressions.
出处 《广东医学》 CAS CSCD 北大核心 2013年第19期2914-2917,共4页 Guangdong Medical Journal
基金 广东省湛江市科技计划项目(编号:2010C3102002)
关键词 淫羊藿 糖皮质激素 肾脏 骨形态发生蛋白-7 epimedium glucoeorticoid kidney bone morphogenetic protein - 7
  • 相关文献

参考文献12

  • 1莫樱.糖皮质激素对肾脏的不良作用[J].国外医学(儿科学分册),1997,24(2):69-72. 被引量:1
  • 2曾庆岳,王云山.淫羊藿药理作用研究进展[J].医药导报,2012,31(4):462-465. 被引量:64
  • 3NIKSIC L, MARTIN P Y. BMP-7 ( Bone morphogenetic protein-7) : a future treatment for chronic renal failure? [ J]. Rev MedSuisse,2005 , 1(8) : 568 -570, 572 -573.
  • 4BIYIKLI NK,TUGTEPE H,CAKALAGAOGLU F, et al. Down-regulation of the expression of bone morphogenetic protein 7 in ex-perimental pyelonephritis [ J ]. Pediatr Nephrol,2005,20 ( 9 ):1230 -1236.
  • 5LECLERC N, LUPPEN C A, HO V V, et al. Gene expressionprofiling of glucocorticoid - inhibited osteoblasts [ J ]. J MolEndocrinol, 2004, 33(1) : 175 -193.
  • 6GOULD S E, DAY M, JONES SS, et al. BMP-7 regulates che-mokine, cytokine, and hemodynamic gene expression in proximaltubule cells [ J ]. Kidney Int, 2002 , 61(1) : 51 -60.
  • 7HAO Z M, CAI M, LV Y F, et al. Oral administration of recom-binant adeno - associated virus - mediated bone morphogeneticprotein - 7 suppresses CC14 — induced hepatic fibrosis in mice[ J ].Mol Ther, 2012,20(11) : 2043 -2051.
  • 8YANAGITA M. Inhibitors/antagonists of TGF - beta system inkidney fibrosis [ J ]. Nephrol Dial Transplant, 2012,27(10):3686 -3691.
  • 9MENG X M,CHUNG A C, LAN H Y. Role of the TGF - beta/BMP -7/Smad pathways in renal diseases[ J]. Clin Sci ( Lond),2013, 124(4) : 243 -254.
  • 10LEE K B, TAGHAVI C E, MURRAY S S, et al. BMP inducedinflammation: A comparison of rhBMP - 7 and rhBMP - 2 [ J]. JOrthop Res, 2012, 30(12): 1985 -94.

二级参考文献62

共引文献87

同被引文献123

引证文献4

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部